Intervention

Flortaucipir F18

ClinicalTrials.gov intervention label

Clinical trials15
Recruiting1
Common conditions5
Lead sponsors shown2

Clinical trials

15 shown
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseNCT06297590 · 2024-08-15
RECRUITING
Tau Screening Study in Subjects With Early Symptomatic ADNCT03467477 · 2018-03-08
COMPLETED
Tau Screening Study in Patients With Early Symptomatic ADNCT03322462 · 2017-11-21
COMPLETED
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's DiseaseNCT03019536 · 2017-01-31
COMPLETED
18F-AV-1451 High Resolution Autopsy StudyNCT02350634 · 2016-11-26
COMPLETED
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05NCT02795780 · 2016-08-01
COMPLETED
18F-AV-1451 Autopsy StudyNCT02516046 · 2015-09-01
COMPLETED
Tau Imaging in Professional FightersNCT02278354 · 2015-02-18
COMPLETED
Augmenting Flortaucipir Dosimetry EstimatesNCT02336360 · 2015-01-01
COMPLETED
Clinical Evaluation of Flortaucipir F 18NCT02278367 · 2014-12-01
COMPLETED
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's DiseaseNCT04468347 · 2014-10-01
COMPLETED
Imaging Characteristics of a Follow-up 18F-AV-1451 ScanNCT02051764 · 2014-05-01
TERMINATED
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsNCT02016560 · 2013-12-01
COMPLETED
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsNCT01992380 · 2013-11-13
COMPLETED
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsNCT04474405 · 2013-08-16
COMPLETED

Trial status mix

COMPLETED13
RECRUITING1
TERMINATED1

Phase mix

PHASE17
PHASE26
PHASE32
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.